Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPAR? in carbon tetrachloride-treated mice

被引:20
|
作者
Zhang, Lin [1 ]
Zhang, Haibo [2 ]
Gu, Jinhua [1 ]
Xu, Wanqing [3 ]
Yuan, Nianping [1 ]
Sun, Jialin [1 ]
Li, Hua [1 ]
机构
[1] Nantong Univ, Dept Pharm, Affiliated Matern & Child Care Hosp, 399 Century Ave, Nantong 226018, Peoples R China
[2] Nantong Univ, Dept Infect Dis, Affiliated Matern &Child Care Hosp, 399 Century Ave, Nantong 226018, Peoples R China
[3] Nantong Univ, Sch Med, 19 Qixiu Rd, Nantong 226001, Peoples R China
关键词
Glabridin; Liver fibrosis; Hepatic stellate cells; Inflammation; Oxidative stress; PPAR; RECEPTOR-GAMMA;
D O I
10.1016/j.intimp.2022.109433
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Glabridin is an active ingredient extracted from the root of Glycyrrhiza glabra. Previous studies showed that glabridin had potent hepatoprotective effect, however, the effect of glabridin on liver fibrosis and its potential mechanisms remain largely unknown. The present study was aimed to study the effect and potential mechanisms of glabridin on liver fibrosis in carbon tetrachloride (CCl4)-treated mouse livers. Glabridin attenuated the liver injury and improved pathological changes in CCl4-treated mouse livers. Glabridin suppressed the liver fibrosis in CCl4-treated mouse livers, as shown by the decreased collagen deposition, the reduced hydroxyproline level together with the decreased mRNA and protein expression of alpha-SMA, fibronectin and alpha 1(I)procollagen in mouse livers. Interestingly, glabridin increased the mRNA and protein expression of proliferator-activated receptor gamma (PPAR gamma) in CCl4-treated mouse livers. In addition, both immunohistochemistry and tissue immunoflu-orescence showed that glabridin upregulated the expression of PPAR gamma in CCl4-treated mouse livers. Glabridin evidently reduced the levels of pro-inflammatory factors and increased the level of anti-inflammatory factor in CCl4-treated mouse livers and sera. In addition, Glabridin inhibited the level of MDA and increased the level of GSH as well as the total antioxidant capacity (T-AOC) in CCl4-treated mouse livers. In vitro study showed that glabridin reduced the cell viability of PDGF-BB-stimulated JS-1 cells. Noteworthy, glabridin showed no obvious toxicity on normal JS1 cells. Glabridin inhibited the protein expression of alpha-SMA, fibronectin and alpha 1(I)pro-collagen, and increased the expression of PPAR gamma in stimulated JS-1 cells. Furthermore, disruption of PPAR gamma attenuated the anti-inflammatory and anti-oxidative stress effects of glabridin in stimulated JS-1 cells. Collec-tively, glabridin inhibited the liver fibrosis and hepatic stellate cells activation by suppressing inflammation and oxidative stress through activation of PPAR gamma in carbon tetrachloride-treated mice.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
    Senoo, Takemasa
    Sasaki, Ryu
    Akazawa, Yuko
    Ichikawa, Tatsuki
    Miuma, Satoshi
    Miyaaki, Hisamitsu
    Taura, Naota
    Nakao, Kazuhiko
    BMC GASTROENTEROLOGY, 2018, 18
  • [2] Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver
    Reza, Hasan Mahmud
    Tabassum, Nabila
    Sagor, Md Abu Taher
    Chowdhury, Mohammed Riaz Hasan
    Rahman, Mahbubur
    Jain, Preeti
    Alam, Md Ashraful
    TOXICOLOGY MECHANISMS AND METHODS, 2016, 26 (01) : 46 - 53
  • [3] Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
    Takemasa Senoo
    Ryu Sasaki
    Yuko Akazawa
    Tatsuki Ichikawa
    Satoshi Miuma
    Hisamitsu Miyaaki
    Naota Taura
    Kazuhiko Nakao
    BMC Gastroenterology, 18
  • [4] Fuzheng Huayu inhibits carbon tetrachloride-induced liver fibrosis in mice through activating hepatic NK cells
    Cheng, Qi
    Li, Ning
    Chen, Mingquan
    Zheng, Jianming
    Qian, Zhiping
    Wang, Xinyu
    Huang, Chong
    Li, Qian
    Lin, Qingxia
    Shi, Guangfeng
    JOURNAL OF ETHNOPHARMACOLOGY, 2013, 145 (01) : 175 - 181
  • [5] Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells
    Zhao, Xin-Yan
    Zeng, Xin
    Li, Xin-Min
    Wang, Tai-Ling
    Wang, Bao-En
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2009, 36 (10): : 963 - 968
  • [6] Oxidative stress and hepatic stellate cell activation are key events in arsenic induced liver fibrosis in mice
    Ghatak, Subhadip
    Biswas, Ayan
    Dhali, Gopal Krishna
    Chowdhury, Abhijit
    Boyer, James L.
    Santra, Amal
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2011, 251 (01) : 59 - 69
  • [7] Chloroquine Improved Carbon Tetrachloride-Induced Liver Fibrosis through Its Inhibition of the Activation of Hepatic Stellate Cells: Role of Autophagy
    He, Wei
    Wang, Bin
    Yang, Jing
    Zhuang, Yun
    Wang, Liangzhi
    Huang, Xiaodan
    Chen, Jianping
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2014, 37 (09) : 1505 - 1509
  • [8] Cilostazol attenuates hepatic stellate cell activation and protects mice against carbon tetrachloride-induced liver fibrosis
    Saito, Shunichi
    Hata, Koichiro
    Iwaisako, Keiko
    Yanagida, Atsuko
    Takeiri, Masatoshi
    Tanaka, Hirokazu
    Kageyama, Shoichi
    Hirao, Hirofumi
    Ikeda, Kazuo
    Asagiri, Masataka
    Uemoto, Shinji
    HEPATOLOGY RESEARCH, 2014, 44 (04) : 460 - 473
  • [9] Accelerated liver cancer development in Cytoglobin-deficient mice treated with chemicals/diet via the priming of stellate cells and activation of local fibrosis, inflammation, and oxidative stress
    Le, Thuy T.
    Matsumoto, Yoshinari
    Hai, Hoang
    Yoshizato, Katsutoshi
    Kawada, Norifumi
    HEPATOLOGY, 2013, 58 : 1058A - 1058A
  • [10] Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-γ and NF-kB mechanism
    Basso, Bruno de Souza
    Haute, Gabriela Viegas
    Ortega-Ribera, Marti
    Luft, Carolina
    Antunes, Gessica Luana
    Bastos, Matheus Scherer
    Carlessi, Leonardo Pfeiff
    Levorse, Vitor Giancarlo
    Cassel, Eduardo
    Fagundes Donadio, Marcio Vinicius
    Santarem, Eliane Romanato
    Gracia-Sancho, Jordi
    de Oliveira, Jarbas Rodrigues
    JOURNAL OF ETHNOPHARMACOLOGY, 2021, 280